Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
9 stylish white trainers that you can wear with your trousers AND your dresses
Women's white trainers to shop now, from white leather trainers to chunky styles. Shop the best white trainers from adidas, ...